71 related articles for article (PubMed ID: 17369879)
1. Combination of vasostatin and cyclophosphamide in the therapy of murine melanoma tumors.
Jazowiecka-Rakus J; Jarosz M; Kozłowska D; Sochanik A; Szala S
Acta Biochim Pol; 2007; 54(1):125-33. PubMed ID: 17369879
[TBL] [Abstract][Full Text] [Related]
2. Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.
Jazowiecka-Rakus J; Jarosz M; Szala S
Acta Biochim Pol; 2006; 53(1):199-202. PubMed ID: 16388313
[TBL] [Abstract][Full Text] [Related]
3. Vasostatin increases oxygenation of B16-F10 melanoma tumors and raises therapeutic efficacy of cyclophosphamide.
Cichoń T; Jarosz M; Smolarczyk R; Ogórek B; Matuszczak S; Wagner M; Mitrus I; Sochanik A; Jazowiecka-Rakus J; Szala S
Acta Biochim Pol; 2012; 59(3):377-81. PubMed ID: 22946026
[TBL] [Abstract][Full Text] [Related]
4. Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin.
Cai KX; Tse LY; Leung C; Tam PK; Xu R; Sham MH
Clin Cancer Res; 2008 Feb; 14(3):939-49. PubMed ID: 18245558
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis by a synthetic fusion protein VTF derived from vasostatin and tumstatin.
Gu Q; Sun C; Luo J; Zhang T; Wang L
Anticancer Drugs; 2014 Oct; 25(9):1044-51. PubMed ID: 24942148
[TBL] [Abstract][Full Text] [Related]
6. [Construction and activity of recombinant adeno-associated virus expressing vasostatin].
Diao Y; Ma J; Li X; Sun X; Xu R
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1949-54. PubMed ID: 19256344
[TBL] [Abstract][Full Text] [Related]
7. Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function.
Yao L; Pike SE; Tosato G
J Leukoc Biol; 2002 Jan; 71(1):47-53. PubMed ID: 11781379
[TBL] [Abstract][Full Text] [Related]
8. Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice.
Mitrus I; Delić K; Wróbel N; Missol-Kolka E; Szala S
Acta Biochim Pol; 2006; 53(2):357-60. PubMed ID: 16733559
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behavior.
Liu M; Imam H; Oberg K; Zhou Y
Neuroendocrinology; 2005; 82(1):1-10. PubMed ID: 16293970
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin.
Yao L; Pike SE; Pittaluga S; Cherney B; Gupta G; Jaffe ES; Tosato G
Cancer Immunol Immunother; 2002 Sep; 51(7):358-66. PubMed ID: 12192535
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.
Li X; Jiang L; Wang Y; Xiao Y; Huang Y; Yao Q; Yang Y; Wu X
Cancer Lett; 2007 Oct; 256(1):29-32. PubMed ID: 17574330
[TBL] [Abstract][Full Text] [Related]
12. [The angiogenesis inhibitor vasostatin. In tumor inhibiting doses there is no impaired wound healing in the mouse model].
Hautarzt; 2002 Feb; 53(2):154. PubMed ID: 11968171
[No Abstract] [Full Text] [Related]
13. [Bioluminescent imaging monitoring of a anti-angiogenesis therapeutic gene vasostatin in tumor cell PC3].
Hu JM; Qiu FC; Yin B; Gong YH; Yuan JG; Qiang BQ; Wang SZ; Peng XZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):312-7. PubMed ID: 17633454
[TBL] [Abstract][Full Text] [Related]
14. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
[TBL] [Abstract][Full Text] [Related]
15. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
16. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth.
Pike SE; Yao L; Setsuda J; Jones KD; Cherney B; Appella E; Sakaguchi K; Nakhasi H; Atreya CD; Teruya-Feldstein J; Wirth P; Gupta G; Tosato G
Blood; 1999 Oct; 94(7):2461-8. PubMed ID: 10498619
[TBL] [Abstract][Full Text] [Related]
17. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
Lu XL; Jiang XB; Liu RE; Zhang SM
Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
[TBL] [Abstract][Full Text] [Related]
18. Secreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth.
Shen L; Zhu X; Wang Y; Zeng W; Wu G; Xue H; Chen B
Biol Chem; 2008 Feb; 389(2):135-41. PubMed ID: 18163888
[TBL] [Abstract][Full Text] [Related]
19. Combination of combretastatin A4 phosphate and doxorubicin-containing liposomes affects growth of B16-F10 tumors.
Mitrus I; Sochanik A; Cichoń T; Szala S
Acta Biochim Pol; 2009; 56(1):161-5. PubMed ID: 19287800
[TBL] [Abstract][Full Text] [Related]
20. Chimeric protein ABRaA-VEGF121 is cytotoxic towards VEGFR-2-expressing PAE cells and inhibits B16-F10 melanoma growth.
Smagur A; Boyko MM; Biront NV; Cichoń T; Szala S
Acta Biochim Pol; 2009; 56(1):115-24. PubMed ID: 19252752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
